Product image of Mpa Gyn (Medroxyprogesterone Acetate) supplied by GNH India

Mpa Gyn

Active Ingredient:
Medroxyprogesterone Acetate
Origin:
EU

Mpa Gyn (Medroxyprogesterone Acetate)

Medroxyprogesterone acetate, the active ingredient in Mpa Gyn, is a progestogen presented as an oral formulation for oral use. It is employed in gynecological hormone therapy to manage menstrual disorders, endometriosis, secondary amenorrhea, hormone replacement therapy and contraception in women of reproductive age.

GNH India supplies Mpa Gyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hexal Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mpa Gyn, a synthetic progestogen, is used in several gynecological conditions that involve hormonal regulation.

  • Menstrual disorders: helps regularize cycle length and reduce abnormal uterine bleeding.
  • Endometriosis: suppresses ectopic endometrial tissue growth and alleviates pelvic pain.
  • Secondary amenorrhea: induces withdrawal bleeding by stimulating endometrial shedding.
  • Hormone replacement therapy: provides progestogenic support in post‑menopausal regimens.
  • Contraception: prevents ovulation and creates an endometrial environment unsuitable for implantation.

How It Works

  • Medroxyprogesterone acetate binds to progesterone receptors in target tissues, mimicking natural progesterone. This interaction suppresses the hypothalamic‑pituitary‑gonadal axis, inhibiting the mid‑cycle luteinising hormone surge and thereby preventing ovulation. In the endometrium, it induces secretory transformation and stabilises the lining, reducing proliferative activity and menstrual bleeding.

Side Effects

Adverse reactions may occur with any hormonal therapy and should be monitored.

Common Side Effects

  • Weight gain: mild increase in body weight.
  • Headache: transient tension‑type headaches.
  • Nausea: occasional stomach upset.
  • Breast tenderness: mild discomfort or swelling.
  • Mood changes: irritability or mild depressive symptoms.

Serious or Rare Side Effects

  • Thromboembolic events: deep vein thrombosis or pulmonary embolism.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Liver dysfunction: jaundice or elevated liver enzymes.
  • Hyperglycemia: elevated blood glucose in susceptible individuals.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.

  • Contraindications: avoid in patients with known hypersensitivity to medroxyprogesterone acetate.
  • Pregnancy: not recommended during pregnancy; assess risk‑benefit if exposure occurs.
  • Breastfeeding: use with caution; potential excretion in milk.
  • Cardiovascular risk: assess history of thrombosis or cardiovascular disease.
  • Liver disease: monitor hepatic function in patients with pre‑existing liver conditions.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Medroxyprogesterone acetate may alter the efficacy of several concomitant medicines.

Major Interactions (Avoid)

  • Anticoagulants: may increase bleeding risk; monitor INR or clotting parameters.
  • CYP3A4 inducers (e.g., rifampicin, carbamazepine): can reduce plasma levels and effectiveness.

Moderate Interactions (Monitor Closely)

  • Antidiabetic agents: progestogens can affect glucose control; adjust monitoring.
  • Antihypertensives: possible fluid retention may influence blood pressure.
  • Other hormonal agents: combined use may increase risk of thromboembolism.

Frequently Asked Questions

Mpa Gyn contains medroxyprogesterone acetate, a synthetic progestogen used to manage menstrual disorders, endometriosis, secondary amenorrhea, hormone replacement therapy in post‑menopausal women, and as a component of certain contraceptive regimens. It works by modulating the hormonal environment of the uterus and ovaries.

Medroxyprogesterone acetate binds to progesterone receptors, suppressing the luteinising hormone surge that triggers ovulation and inducing secretory changes in the endometrium. This dual action helps regulate menstrual cycles, reduces abnormal uterine bleeding, and creates a hormonal milieu that is unfavorable for implantation.

The specific dose of Mpa Gyn is determined by the prescribing clinician based on the individual’s indication, age, weight, and medical history. Healthcare professionals tailor the regimen to achieve the desired therapeutic effect while minimizing potential adverse reactions.

Mpa Gyn is generally contraindicated during pregnancy because it can affect fetal development. Its safety during breastfeeding is not well established; therefore, clinicians usually advise caution and assess the risk‑benefit ratio before prescribing to nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mpa Gyn’s active ingredient, medroxyprogesterone acetate, offers a longer half‑life and stronger progestogenic activity compared with some natural progesterone preparations. This can provide more consistent cycle control but may also be associated with a higher incidence of certain side effects, such as weight gain or mood changes, relative to shorter‑acting agents.

Mpa Gyn should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat and direct sunlight, and ensure the packaging remains tightly closed until use.

Mpa Gyn is taken orally, usually with water. The exact timing (e.g., with food or on an empty stomach) and frequency are determined by the prescribing physician based on the therapeutic indication and patient-specific factors.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe allergic reactions, and liver dysfunction. Patients should be monitored for signs of swelling, pain, shortness of breath, jaundice, or unexplained fatigue, and seek immediate medical attention if these occur.

Mpa Gyn is contraindicated in individuals with known hypersensitivity to medroxyprogesterone acetate, active or past thromboembolic disease, uncontrolled hypertension, severe liver disease, or known pregnancy. Clinicians should also exercise caution in patients with a history of breast cancer or other hormone‑sensitive malignancies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Medroxyprogesterone Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT